Bone Therapeutics and Implant Therapeutics announced the signing of a research evaluation agreement. The agreement will enable Bone Therapeutics to access, evaluate and materially transfer Implant Therapeutics’ iPSC lines, media, differentiation protocols and expertise.
[Bone Therapeutics]
7992332
{7992332:CCCCCCCC}
apa
50
1
167246
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
